Tag: ATS

cystic fibrosis lungs
Respiratory

CF Patients Experience Improved Lung Health with Lumacaftor-Ivacaftor But with Caveats

In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI®), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. However, […]

banned
Respiratory

Michigan Governor Bans All Flavored Vaping Products

The American Thoracic Society applauds Michigan Governor Gretchen Whitmer’s decision to ban the sale of all flavored e-cigarette and vaping products in the state of Michigan. Governor Whitmer’s decision is an appropriate response to the 215 recently reported cases of e-cigarette triggered acute illnesses that have resulted in hospitalization and in at […]